P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C

• Melissa Alsina,
• Madhav Dhodapkar,
• Jesus Berdeja,
• Krina Patel,
• Shambavi Richard,
• Ravi Vij,
• Xavier Leleu,
• Daniel Egan,
• P. Leif Bergsagel,
• Reshef Ran,
• Saad Z Usmani,
• Anna Truppel-Hartmann,
• Debashree Basudhar,
• Ethan Thompson,
• Xirong Zheng,
• Xiaobo Zhong,
• Chiara Greggio,
• Mihaela Popa Mckiver,
• Marlene Carrasco Alfonso,
• David Siegel

Affiliations

Melissa Alsina

1 Moffitt Cancer Center, Tampa, United States

Madhav Dhodapkar

2 Emory University, Atlanta, United States

Jesus Berdeja

3 Sarah Cannon Research Institute, Nashville, United States

Krina Patel

4 MD Anderson Cancer Center, Houston, United States

Shambavi Richard

5 Mount Sinai Hospital, New York, United States

Ravi Vij

6 Washington University, St Louis, MO, United States

Xavier Leleu

7 CHU La Milétrie, Poitiers, France

Daniel Egan

8 Swedish Center for Blood Disorders and Stem Cell Transplants, Seattle, WA, United States

P. Leif Bergsagel

9 Mayo Clinic Arizona, Phoenix, AZ, United States

Reshef Ran

10 Columbia University Irving Medical Center, New York, NY, United States

Saad Z Usmani

11 Memorial Sloan Kettering Cancer Center, New York, NY, United States

Anna Truppel-Hartmann

12 2seventy bio, Cambridge, MA, United States

Debashree Basudhar

13 Bristol Myers Squibb, Princeton, NJ, United States

Ethan Thompson

13 Bristol Myers Squibb, Princeton, NJ, United States

Xirong Zheng

13 Bristol Myers Squibb, Princeton, NJ, United States

Xiaobo Zhong

13 Bristol Myers Squibb, Princeton, NJ, United States

Chiara Greggio

14 Bristol Myers Squibb, Boudry, Switzerland

Mihaela Popa Mckiver

13 Bristol Myers Squibb, Princeton, NJ, United States

Marlene Carrasco Alfonso

13 Bristol Myers Squibb, Princeton, NJ, United States

David Siegel

15 Hackensack University John Theurer Cancer Center, Hackensack, NJ, United States